# Shineco, Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/fi/companies/Shineco, Inc.).

## Overview

Shineco, Inc. is a Delaware holding company whose operating businesses have been conducted primarily through subsidiaries in the People’s Republic of China. Its reported activities include rapid diagnostic and other medical products, healthy meal products, agricultural products such as Luobuma products, and logistics and processing services.

## Products & services

• Rapid diagnostic and other medical products
• Healthy meal products
• Luobuma and other agricultural products
• Logistics and freight forwarding services
• Processing services for external customers

- **Rapid diagnostic and medical products** (80%) — Diagnostic products and related medical devices sold through the Biowin business.
- **Healthy meal products** (5%) — Prepared healthy meals for people with slow metabolic health and recovery needs.
- **Agricultural products** (10%) — Luobuma products and other agricultural goods sold through the company’s product channels.
- **Logistics and processing services** (5%) — Domestic freight forwarding and other processing services provided to external customers.

- Rapid diagnostic and other medical products
- Healthy meal products
- Luobuma and other agricultural products
- Logistics and freight forwarding services
- Processing services for external customers

## Customers

The company sells to customers that buy diagnostic and medical products for common disease testing and related use cases, as well as buyers of agricultural and food products in its operating markets. It also serves service customers that need freight forwarding or processing support, where the company acts either as principal or agent depending on the transaction.

- **Diagnostic and medical product customers** (primary) — Buy rapid diagnostic and related medical devices for common disease testing and related healthcare use.
- **Agricultural product buyers** (secondary) — Purchase Luobuma and other agricultural products through the company’s product channels.
- **Healthy meal customers** (secondary) — Buy healthy meal products aimed at people with slow metabolic health or recovery needs.
- **Logistics and processing service customers** (emerging) — Use freight forwarding and processing services for shipment handling and related operations.

- Medical product buyers needing rapid diagnostic and related devices
- Consumers or distributors purchasing healthy meal products
- Customers buying Luobuma and other agricultural products
- Logistics customers needing domestic freight forwarding services
- Processing-service customers where the company may act as agent

## Geography

Shineco’s operating activities are conducted primarily in the PRC, while the parent company is incorporated in Delaware and its common stock is listed in the United States. The business is therefore exposed to Chinese operating, regulatory, and currency conditions, even though the capital markets presence is U.S.-based.

- Operating businesses are primarily in the People’s Republic of China
- Delaware holding company structure with U.S. listing
- PRC regulatory and currency conditions affect operations
- No country-level revenue disclosure was provided in the excerpts

## Strategy

The company’s stated priorities are to develop new products, expand its distribution network, and pursue growth through possible mergers and acquisitions of similar or synergistic businesses. It also emphasizes supplier relationships and cost control to support product availability and scale across its operating channels.

- **Product development** (medium-term) — Broader product offerings can support demand capture across healthcare, food, and agriculture channels.
- **Distribution expansion** (medium-term) — A wider distribution network improves market reach and customer access.
- **Selective acquisitions** (medium-term) — M&A could add complementary products, customers, or operating scale.
- **Supplier and cost control** (short-term) — Stable supply and competitive input pricing are important for product availability and margins.

- Develop new products across medical, food, and agricultural lines
- Expand distribution network to reach more customers and markets
- Pursue possible mergers and acquisitions when attractive
- Strengthen supplier alliances to secure material supply
- Use nationwide distribution and diversified offerings to scale

## Risks

Shineco faces going-concern, liquidity, and Nasdaq listing risks tied to recurring losses, negative working capital, and reliance on external financing. Its operations are concentrated in the PRC, which creates exposure to Chinese regulatory, political, legal, and currency risks, while its revenue mix also depends on customer demand for product categories that can be volatile.

- **Going-concern and liquidity pressure** [critical] — Recurring losses, negative working capital, and operating cash outflows can limit funding flexibility.
- **PRC regulatory and political exposure** [high] — Operations are primarily in China, where policy, legal, and currency changes can affect results.
- **Nasdaq listing compliance** [high] — Failure to meet continued listing requirements could lead to delisting and reduced market access.
- **Demand concentration and product mix volatility** [medium] — Revenue depends on orders for specific product lines, which can fluctuate materially quarter to quarter.

- Going-concern risk from recurring losses and negative working capital
- Dependence on stockholder, equity, and debt financing
- PRC regulatory, political, legal, and foreign exchange exposure
- Customer demand volatility in diagnostic and product businesses
- Nasdaq delisting risk if listing requirements are not met

## Accounting

Revenue is recognized under ASC 606 when control transfers, with product sales generally recognized at delivery and service revenue recognized when the service is performed. Investors should also watch estimates around credit losses, inventory reserves, long-lived asset recoverability, and valuation allowances, because these judgments can materially affect reported earnings and asset values.

- **Revenue recognition under ASC 606** — Affects reported revenue timing and gross versus net presentation
- **Credit loss allowance** — Affects bad-debt expense and asset carrying values
- **Inventory reserve** — Affects cost of revenue and gross margin
- **Long-lived asset recoverability** — Can trigger impairment charges

- Point-in-time revenue recognition for product sales at delivery
- Agent versus principal assessment for service transactions
- Expected credit loss estimates for receivables and loans
- Inventory reserves and net realizable value judgments
- Recoverability of long-lived assets and valuation allowances

---

*Last updated: 2026-04-29T04:55:10.662884+00:00*